binding affinity News and Research

RSS
Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

Mutations in SARS-CoV-2 Omicron variant promote cell binding

Mutations in SARS-CoV-2 Omicron variant promote cell binding

Exploring the structural basis of antibody evasion and enhanced transmission of the SARS-CoV-2 Omicron variant

Exploring the structural basis of antibody evasion and enhanced transmission of the SARS-CoV-2 Omicron variant

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Forecasting seasonal SARS-CoV-2 mutations

Forecasting seasonal SARS-CoV-2 mutations

Engineering higher affinity SARS-CoV-2 antibodies

Engineering higher affinity SARS-CoV-2 antibodies

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Emerging SARS-CoV-2 B.1.619 and B.1.620 variants in South Korea

Emerging SARS-CoV-2 B.1.619 and B.1.620 variants in South Korea

SARS-CoV-2 Omicron a product of offensive evolution with compromised antigenicity

SARS-CoV-2 Omicron a product of offensive evolution with compromised antigenicity

Researchers isolate Omicron variant, leveling the path to vaccine development and vaccine efficacy studies

Researchers isolate Omicron variant, leveling the path to vaccine development and vaccine efficacy studies

Serological antibody response to SARS-CoV-2 infection at a population level

Serological antibody response to SARS-CoV-2 infection at a population level

Scientists provide a structural framework for Omicron immune evasion and ACE2 receptor recognition

Scientists provide a structural framework for Omicron immune evasion and ACE2 receptor recognition

Study finds pan-sarbecovirus nanobodies can enhance development of super-immunity

Study finds pan-sarbecovirus nanobodies can enhance development of super-immunity

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

Production of molecular probes of spike and subdomains for all SARS-CoV-2 variants

Production of molecular probes of spike and subdomains for all SARS-CoV-2 variants

The impact of natural selection on sequence diversity in SARS-CoV-2

The impact of natural selection on sequence diversity in SARS-CoV-2

Humanized antibody shows strong neutralization ability against SARS-CoV-2 Delta variant

Humanized antibody shows strong neutralization ability against SARS-CoV-2 Delta variant